Authors:
KOHLER S
PRIETL G
SCHMOLLING J
GRUNN U
FISCHER HP
SCHLEBUSCH H
WAGNER U
Citation: S. Kohler et al., IMMUNOTHERAPY OF OVARIAN-CARCINOMA WITH T HE MONOCLONAL ANTIIDIOTYPE ANTIBODY ACA125 - RESULTS OF THE PHASE-IB STUDY, Geburtshilfe und Frauenheilkunde, 58(4), 1998, pp. 180-186
Authors:
WAGNER U
SCHLEBUSCH H
KOHLER S
SCHMOLLING J
GRUNN U
KREBS D
Citation: U. Wagner et al., IMMUNOLOGICAL RESPONSES TO THE TUMOR-ASSOCIATED ANTIGEN CA125 IN PATIENTS WITH ADVANCED OVARIAN-CANCER INDUCED BY THE MURINE MONOCLONAL ANTIIDIOTYPE VACCINE ACA125, Hybridoma, 16(1), 1997, pp. 33-40
Authors:
SCHLEBUSCH H
REINARTZ S
KAISER R
GRUNN U
WAGNER U
Citation: H. Schlebusch et al., PRODUCTION OF A SINGLE-CHAIN FRAGMENT OF THE MURINE ANTIIDIOTYPIC ANTIBODY ACA125 AS PHAGE-DISPLAYED AND SOLUBLE ANTIBODY BY RECOMBINANT PHAGE ANTIBODY TECHNIQUE, Hybridoma, 16(1), 1997, pp. 47-52
Citation: H. Schlebusch et al., A MONOCLONAL ANTIIDIOTYPIC ANTIBODY ACA-125 MIMICKING THE TUMOR-ASSOCIATED ANTIGEN CA-125 FOR IMMUNOTHERAPY OF OVARIAN-CANCER, Hybridoma, 14(2), 1995, pp. 167-174
Citation: M. Niesen et al., FRUCTOSAMINE, INSULIN AND C-PEPTIDE IN NE WBORN OF MOTHERS WITH AND WITHOUT DIABETES, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 1418-1419